E3 THERAPEUTICS

E3 Therapeutics Inc. is a biotech company focusing on the selective and efficient ubiquitination of proteins that play a role in the development and proliferation of diseases. E3 utilizes a proprietary amalgam of next-gen technologies-including artificial intelligence, computational chemistry, and medicinal and synthetic chemistry that facilitate the drug discovery and development process. E3 is focused on applying their novel technology/platform to therapeutic programs ranging from oncology, inflammatory and cardiovascular and central nervous system diseases... To address this issue, E3 Therapeutics Inc. has designed a series of lead compounds that can simultaneously bind to three different homologous E3 ubiquitin ligases. This expands upon existing PROTAC viability and makes it possible to construct therapeutics with increased efficacy and decreased drug resistance.

Also known as: E3 Therapeutics Inc.

Primary location: Edmonton